Antibody Shows Promise Against Obesity-related Liver Disease and Atherosclerosis in Mice

Latest research in the FASEB Journal reveals an antibody called bFKB1 improves liver disease and atherosclerosis in a mouse model of metabolic dysfunction-associated steatohepatitis (MASH), which is associated with obesity. 

Read More